BIT — Biotron Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro CapNeutral
- AU$42.12m
- AU$39.86m
- AU$1.46m
- 43
- 12
- 32
- 19
Annual cashflow statement for Biotron, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2017 June 30th | 2018 June 30th | 2019 June 30th | 2020 June 30th | 2021 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -2.95 | -1.85 | -0.991 | -2.44 | -3.49 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.83 | -1.84 | -1.5 | -3.08 | -3.41 |
| Capital Expenditures | -0.005 | 0 | -0.041 | 0 | -0.006 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.006 | 0 | -0.012 | 0 | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.012 | 0 | -0.053 | 0 | -0.006 |
| Financing Cash Flow Items | -0.164 | -0.256 | -0.292 | -0.275 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.41 | 1.4 | 5.75 | 5 | -0.037 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.43 | -0.444 | 4.2 | 1.92 | -3.45 |